Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing innovative products focused on the treatment or prevention of gastrointestinal cancers is pleased to ...

CHICAGO--(BUSINESS WIRE)--Emalex Biosciences today announced that the U.S. Food and Drug Administration has authorized the company’s Expanded Access Program (EAP) for ecopipam, an investigational ...

Who takes care of caregivers? ACCESS aims to answer that with Exhale: a program offering resources, community support and expert guidance to ease the challenges of senior caregiving. The program's ...

Cognition Therapeutics, Inc. announced the initiation of an expanded access program (EAP) funded by an anonymous philanthropic donation from the family of a patient with dementia with Lewy bodies (DLB ...

As updated coronavirus vaccines hit U.S. pharmacy shelves, adults without health insurance are discovering the shots are no longer free, instead costing up to $200. The federal Bridge Access Program ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

SAN FRANCISCO--(BUSINESS WIRE)--In response to the growing demand for a transformative approach to identity management, AKA Identity launched today its cutting-edge platform early access program. This ...

Germany has become the first EU country to introduce a compassionate access program for the use of psilocybin in treatment-resistant depression. “Experience from Switzerland shows that demand far ...

The University of New Haven collaborates with select community-based organizations & high schools as a college-access resource for their students. Through this allyship students have opportunities to ...